About This Test
ROS1 is a receptor tyrosine kinase with structural similarity to Anaplastic Lymphoma Kinase (ALK) protein. In patients with Non Small Cell Lung cancer (NSCLC), ROS1 expression is found in approximately 2% of these patients who tend to be younger with a median age of 49 years, no history of smoking & with a diagnosis of Adenocarcinoma. Detection of ROS1 in lung cancer is important for optimal treatment as it can be efficiently inhibited by tyrosine kinase inhibitor Crizotinib.
Home Collection
✗ Not Available
Reports Available In
1 Day
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Provide a copy of the Histopathology report.
ROS1 is a receptor tyrosine kinase gene that can undergo rearrangements or fusions in certain cancers, leading to uncontrolled cell growth. IHC testing for ROS1 helps identify ROS1-positive tumors, which are eligible for targeted therapy.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
